Repeated administration of the novel antiepileptic agent levetiracetam does not alter digoxin pharmacokinetics and pharmacodynamics in healthy volunteers
- 13 July 2001
- journal article
- clinical trial
- Published by Elsevier in Epilepsy Research
- Vol. 46 (2) , 93-99
- https://doi.org/10.1016/s0920-1211(01)00253-4
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Pharmacokinetic profile of levetiracetamPharmacology & Therapeutics, 2000
- Atorvastatin Coadministration May Increase Digoxin Concentrations by Inhibition of Intestinal P-Glycoprotein-Mediated SecretionThe Journal of Clinical Pharmacology, 2000
- Longitudinal assessment of a P-glycoprotein?mediated drug interaction of valspodar on digoxinClinical Pharmacology & Therapeutics, 1999
- P-GLYCOPROTEIN SYSTEM AS A DETERMINANT OF DRUG INTERACTIONS: THE CASE OF DIGOXIN–VERAPAMILPharmacological Research, 1999
- The role of intestinal P-glycoprotein in the interaction of digoxin and rifampinJournal of Clinical Investigation, 1999
- Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsyPublished by Elsevier ,1998
- Tiagabine, a novel antiepileptic agent: lack of pharmacokinetic interaction with digoxin.European Journal of Clinical Pharmacology, 1998
- Itraconazole Decreases Renal Clearance of DigoxinTherapeutic Drug Monitoring, 1997
- Drug Interaction Profile of TopiramateEpilepsia, 1996
- On the interaction between phenytoin and digoxinEuropean Journal of Clinical Pharmacology, 1985